Endourologic Management of Upper Tract Transitional Cell Carcinoma following Cystectomy and Urinary Diversion
Traditionally, nephroureterectomy is the gold standard therapy for upper tract recurrence of transitional cell carcinoma (TCC) following cystectomy and urinary diversion. With advances in endoscopic equipment and improvements in technique, conservative endourologic management via a retrograde or ant...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | Advances in Urology |
| Online Access: | http://dx.doi.org/10.1155/2009/976401 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832559944733294592 |
|---|---|
| author | Jeffrey John Tomaszewski Marc Christopher Smaldone Michael Cecil Ost |
| author_facet | Jeffrey John Tomaszewski Marc Christopher Smaldone Michael Cecil Ost |
| author_sort | Jeffrey John Tomaszewski |
| collection | DOAJ |
| description | Traditionally, nephroureterectomy is the gold standard therapy for upper tract recurrence of transitional cell carcinoma (TCC) following cystectomy and urinary diversion. With advances in endoscopic equipment and improvements in technique, conservative endourologic management via a retrograde or antegrade approach is technically feasible with acceptable outcomes in patients with bilateral disease, solitary renal units, chronic renal insufficiency, or significant medical comorbidities. Contemporary studies have expanded the utility of these techniques to include low-grade, low-volume disease in patients with a normal contralateral kidney. The aim of this report is to review the current outcomes of conservative management for upper tract disease and discuss its application and relevance in patients following cystectomy with lower urinary tract reconstruction. |
| format | Article |
| id | doaj-art-feae971f89d04b54823fe7b50a90ea53 |
| institution | Kabale University |
| issn | 1687-6369 1687-6377 |
| language | English |
| publishDate | 2009-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Advances in Urology |
| spelling | doaj-art-feae971f89d04b54823fe7b50a90ea532025-02-03T01:28:49ZengWileyAdvances in Urology1687-63691687-63772009-01-01200910.1155/2009/976401976401Endourologic Management of Upper Tract Transitional Cell Carcinoma following Cystectomy and Urinary DiversionJeffrey John Tomaszewski0Marc Christopher Smaldone1Michael Cecil Ost2Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USADepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USADepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USATraditionally, nephroureterectomy is the gold standard therapy for upper tract recurrence of transitional cell carcinoma (TCC) following cystectomy and urinary diversion. With advances in endoscopic equipment and improvements in technique, conservative endourologic management via a retrograde or antegrade approach is technically feasible with acceptable outcomes in patients with bilateral disease, solitary renal units, chronic renal insufficiency, or significant medical comorbidities. Contemporary studies have expanded the utility of these techniques to include low-grade, low-volume disease in patients with a normal contralateral kidney. The aim of this report is to review the current outcomes of conservative management for upper tract disease and discuss its application and relevance in patients following cystectomy with lower urinary tract reconstruction.http://dx.doi.org/10.1155/2009/976401 |
| spellingShingle | Jeffrey John Tomaszewski Marc Christopher Smaldone Michael Cecil Ost Endourologic Management of Upper Tract Transitional Cell Carcinoma following Cystectomy and Urinary Diversion Advances in Urology |
| title | Endourologic Management of Upper Tract Transitional Cell Carcinoma following Cystectomy and Urinary Diversion |
| title_full | Endourologic Management of Upper Tract Transitional Cell Carcinoma following Cystectomy and Urinary Diversion |
| title_fullStr | Endourologic Management of Upper Tract Transitional Cell Carcinoma following Cystectomy and Urinary Diversion |
| title_full_unstemmed | Endourologic Management of Upper Tract Transitional Cell Carcinoma following Cystectomy and Urinary Diversion |
| title_short | Endourologic Management of Upper Tract Transitional Cell Carcinoma following Cystectomy and Urinary Diversion |
| title_sort | endourologic management of upper tract transitional cell carcinoma following cystectomy and urinary diversion |
| url | http://dx.doi.org/10.1155/2009/976401 |
| work_keys_str_mv | AT jeffreyjohntomaszewski endourologicmanagementofuppertracttransitionalcellcarcinomafollowingcystectomyandurinarydiversion AT marcchristophersmaldone endourologicmanagementofuppertracttransitionalcellcarcinomafollowingcystectomyandurinarydiversion AT michaelcecilost endourologicmanagementofuppertracttransitionalcellcarcinomafollowingcystectomyandurinarydiversion |